Demis Hassabis, CEO of DeepMind, revealed that AI can drastically shorten drug discovery timelines, potentially reducing ...

It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but ...

Millions in military and development funds for Colombia hang in the balance as Washington questions the country’s fight ...

Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them.

Despite the widespread use of artificial intelligence (AI) to make sense of the large amount of health data being generated, drug development continues to be a long and arduous endeavor. Although the ...

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...

Instead of Red No. 40, Yellow No. 5 and Yellow No. 6, the snacks will be colored with a mix of beets, radishes, paprika, ...

High U.S. drug costs spark debate. Lessons from global policies—value-based pricing, reference pricing, and ...

Growing concern over arsenic in the food supply, including foods such as rice, is valid. High arsenic levels are linked to ...

González, Paul Negulescu, and Michael Welsh received the 2025 Lasker Clinical Medical Research Award for the development of a ...

Generative AI, once seen as a tool for writers and artists, is now reshaping the high-stakes world of pharma regulation.

Defense Secretary Pete Hegseth claimed he had the “absolute” authority to conduct a military strike on suspected drug ...